NeuBase Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2020 to 2022

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2022.
  • NeuBase Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 2.76M shares, a 70.8% increase year-over-year.
  • NeuBase Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 32.5M shares, a 19% increase from 2021.
  • NeuBase Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 27.3M shares, a 39.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 32.5M +5.18M +19% Oct 1, 2021 Sep 30, 2022 10-K 2022-12-21
2021 27.3M +7.69M +39.2% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-21
2020 19.6M Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.